RxSight, Inc. Income Statement
RXST|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
RxSight, Inc. reported $89M in revenue and $49M in net loss for FY2025. Revenue has grown at a 57.0% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $89.1M | $49.0M | $49.0M | $22.6M | $14.7M |
| Cost of Revenue | $35.3M | $27.7M | $27.7M | $18.1M | $13.0M |
| Gross Profit | $53.8M | $21.3M | $21.3M | $4.5M | $1.7M |
| SG&A Expense | $74.8M | $58.7M | $58.7M | $32.8M | $15.2M |
| R&D Expense | $29.1M | $26.0M | $26.0M | $24.5M | $21.9M |
| Operating Income | -$50.1M | -$63.3M | -$63.3M | -$52.8M | -$35.4M |
| Interest Expense | $3.3M | $4.9M | $4.9M | $3.7M | $510.0K |
| Income Tax | $20.0K | $9.0K | $9.0K | $8.0K | $57.0K |
| Net Income | -$48.6M | -$66.8M | -$66.8M | -$48.7M | $27.6M |
| EPS (Basic) | -$1.41 | -$2.41 | -$2.41 | -$3.57 | $0.91 |
| EPS (Diluted) | -$1.41 | -$2.41 | -$2.41 | -$3.57 | $0.15 |
| Shares Outstanding | 40.4M | 36.1M | 28.3M | 27.4M | 27.4M |
| Gross Margin | 60.4% | 43.5% | 43.5% | 20.0% | 11.6% |
| Operating Margin | -56.2% | -129.2% | -129.2% | -233.6% | -241.3% |
| Profit Margin | -54.6% | -136.2% | -136.2% | -215.5% | 187.9% |